Atlas Trials

Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013)

Clinical trial NCT01390428 · COMPLETED

Trial details

NCT number
NCT01390428
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2011-07-28
Primary completion
2014-09-05
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.